- Curhan G, Willett W, Speizer F, et al (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497–504 [CrossRef] [PubMed] [Google Scholar]
- Borghi L, Mershi T, Amato F, et al (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–43 [CrossRef] [PubMed] [Google Scholar]
- Suki W, Yium J, Von Minden M, et al (1970) Acute treatment of hypercalcemia with furosemide. N Eng J Med 283:836–40 [CrossRef] [Google Scholar]
- LeGrand S, Leskuski D, Zama I (2008) Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 149:259–63 [CrossRef] [PubMed] [Google Scholar]
- Singer D, Markandu N, Morton J, et al (1994) Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans. Am J Physiol Renal 266:F89–F93 [Google Scholar]
- Heyman SN, Brezis M, Reubinoff CA, et al (1988) Acute renal failure with selective medullary injury in the rat. J Clin Invest 82:401–12 [CrossRef] [PubMed] [Google Scholar]
- Heyman S, Rosen S, Epsein F, et al (1994) Loop diuretics reduce hypoxic damage to proximal tubules of isolated perfused rat kidney. Kidney Int 45:981–85 [CrossRef] [PubMed] [Google Scholar]
- Kuhlik A, Epstein F, Fladi D, et al (1995) Urinary prostaglandin E2 and dopamine responses to water loading in young and elderly humans. Geriatric Nephrol Urol 5:79–83 [CrossRef] [Google Scholar]
- Gerber J (1983) Role of prostaglandins in the hemodynamic and tubular effects of furosemide. Fed Proc 42:1707–10 [PubMed] [Google Scholar]
- Prasad P, Edelman RR, Epstein FH (1996) Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 94:3271–78 [CrossRef] [PubMed] [Google Scholar]
- Sendeski M, Patzak A, Persson PB (2010) Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents. Invest Radiol 45:453–57 [CrossRef] [PubMed] [Google Scholar]
- Heyman S, Rosen S, Khamaisi M, et al (2010) Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 45:188–95 [CrossRef] [PubMed] [Google Scholar]
- Romano G, Briguori C, Quintavalle C, et al (2008) Contrast agents and renal cell apoptosis. Eur Heart J 29:2569–76 [CrossRef] [PubMed] [Google Scholar]
- Majumdar SR, Kjellstrand CM, Tymchak WJ, et al (2009) Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis 54:602–9 [CrossRef] [PubMed] [Google Scholar]
- Solomon R, Werner C, Mann D, et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–20 [CrossRef] [PubMed] [Google Scholar]
- Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413–15 [CrossRef] [PubMed] [Google Scholar]
- Stevens MA, McCullough P, Tobin K, et al (1999) A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. J Am Coll Cardiol 33:403–11 [CrossRef] [PubMed] [Google Scholar]
- Marenzi G, Ferrari C, Marana I, et al (2012) Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial. JACC Cardiovasc Interv 5:90–97 [CrossRef] [PubMed] [Google Scholar]
- Usmiani T, Andreis A, Budano C, et al (2016) AKIGUARD (Acute Kidney Injury GUARding Device) trial: In-hospital and one-year outcomes. J Cardiovasc Med (Hagerstown) 17:530–7 [CrossRef] [PubMed] [Google Scholar]
- Barbanti M, Gulino S, Capranzano P, et al (2015) Acute kidney injury with the RenalGuard System in patients undergoing transcatheter aortic valve replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv 8:1595–604 [CrossRef] [PubMed] [Google Scholar]
- Visconti G, Focaccio A, Donahue M, et al (2016) RenalGuard system for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. EuroIntervention 11:e1658–e61 [CrossRef] [PubMed] [Google Scholar]
- Briguori C, Visconti G, Donahue M, et al (2016) RenalGuard system in high-risk patients for contrast-induced acute kidney injury. Am Heart J 173:67–76 [CrossRef] [PubMed] [Google Scholar]
- Mehran R, Aymong ED, Nikolsky E, et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 44: 1393–9 [PubMed] [Google Scholar]
- Briguori C, Visconti G, Focaccio A, et al (2011) Renal insufficiency after contrast media administration trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 124:1260–9 [CrossRef] [PubMed] [Google Scholar]
- Dussol B, Morange S, Loundoun A, et al (2006) A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 21:2120–6 [CrossRef] [PubMed] [Google Scholar]
- Birtch A, Zakheim R, Jones L, et al (1967) Redistribution of renal blood flow produced by furosemide and ethacrynic acid. Circ Res 21: 869–78 [CrossRef] [PubMed] [Google Scholar]
Accès gratuit
| Numéro |
Méd. Intensive Réa.
Volume 25, Numéro 6, Novembre 2016
Néphrologie et métabolisme
|
|
|---|---|---|
| Page(s) | 591 - 596 | |
| Section | Update / Mise au point | |
| DOI | https://doi.org/10.1007/s13546-016-1231-2 | |
| Publié en ligne | 4 octobre 2016 | |
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.